MAPT and Cognitive impairment: Reduced IL-1β and IL-6 productionAttenuated tau phosphorylationReduced IL-1β and TNF-α productionEnhanced AMPK activityInhibited IRE1α and PERK phosphorylation, NLRP3 expression, and tau phosphorylationImproved cognitive disorder